+20 2 3854 0000 info@tulkpharma.com
EN ع
Home About Products Newsroom Quality & Compliance Careers Contact
Home › Newsroom

Tulkpharma commissions new WHO-GMP production line

Jul 5, 2026

A €12M investment expands capacity for solid-dose manufacturing.

A €12M investment expands capacity for solid-dose manufacturing.

This milestone reflects Tulkpharma's ongoing commitment to quality, capacity and patient access across our therapeutic portfolio.

Newsroom
Newsroom

Latest from the newsroom

Jun 23, 2026

Cardiovita approved in three new markets
May 29, 2026

Tulkpharma partners with university hospitals on research

Tulkpharma is committed to the highest standards of pharmaceutical quality, safety and integrity.

Quick links
About Products Newsroom Contact Quality & ComplianceCareers
Therapeutic areas
Cardiovascular Anti-Infectives Neurology & CNS Gastroenterology Respiratory Women's Health
Contact us
+20 2 3854 0000 info@tulkpharma.com Industrial Zone, 6th of October City, Giza, Egypt
© 2026 Tulkapharma. All rights reserved. Science for healthier lives